Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

All Lyxor indices in positive territory for October; Lyxor Hedge Fund Index up 1.58% for month, 4.8% ytd

Tuesday, November 12, 2013

Beverly Chandler, Opalesque London:

Lyxor reports that all the Lyxor Strategy Indices ended the month of October in positive territory, led by the CTA Long Term (+4.03%), the L/S Equity Market Neutral (+1.77%) and the L/S Equity Long Bias (+1.63%). The Lyxor Hedge Fund Index posted a positive performance of 1.58% in October (+4.80% YTD).

"Markets remain driven by central banks largesse despite signals of economic recovery. High beta strategies have delivered and hedge fund managers are positioned to benefit from it" says Philippe Ferreira, Head of Research and External Relations at Lyxor AM Managed Account Platform. The firm writes that hedge funds were helped by rising asset prices and delivered solid results. Strategies exposed to equities performed the best. The median exposure to equities of all hedge funds remained at the top of the range at 33%, suggesting that managers remain constructive.

Equity strategies generated strong performance with Lyxor’s L/S Equity Long bias up 1.6% in October (13% YTD). "The managers benefited from the high net exposure to equities (73%). L/S Equity Variable bias managers were up 1.6%; with a net exposure at the end of October at 36%. Sector positioning in US equities increased on financials, communication and materials and decreased on Consumer Staples. In Europe, the biggest increase in net exposure was in Communications while net exposure decreased in Industrials and Consumer Staple......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its